Compliance and patching and atropine amblyopia treatments

Vision Res. 2015 Sep;114:31-40. doi: 10.1016/j.visres.2015.02.012. Epub 2015 Mar 2.

Abstract

In the past 20 years, there has been a great advancement in knowledge pertaining to compliance with amblyopia treatments. The occlusion dose monitor introduced quantitative monitoring methods in patching, which sparked our initial understanding of the dose-response relationship for patching amblyopia treatment. This review focuses on current compliance knowledge and the impact it has on patching and atropine amblyopia treatment.

Keywords: Amblyopia; Atropine penalization; Children; Compliance; Occlusion; Patching.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amblyopia / physiopathology
  • Amblyopia / therapy*
  • Atropine / therapeutic use*
  • Child
  • Humans
  • Mydriatics / therapeutic use*
  • Patient Compliance* / psychology
  • Sensory Deprivation / physiology*
  • Visual Acuity / physiology

Substances

  • Mydriatics
  • Atropine